$0.0475
0.002906.50%
At close: -
Comments
Loading...
Galera Therapeutics (OTC:GRTX) Stock, Earnings Estimates, EPS, And Revenue
Galera Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Dec 13
EPS
$-0.100
Quarterly Revenue
$0.00
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Galera Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Galera Therapeutics (GRTX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2024-03-28 | $-0.10 | $-0.35 | 71.4 % |
| Q3 | 2023-11-14 | $-0.33 | $-0.40 | 17.5 % |
| Q2 | 2023-08-14 | $-0.48 | $-0.43 | -11.6 % |
| Q1 | 2023-05-11 | $-0.50 | $-0.38 | -31.6 % |
Galera Therapeutics (GRTX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Galera Therapeutics (OTCPK:GRTX) reporting earnings?
Galera Therapeutics (GRTX) is scheduled to report earnings on March 27, 2025. The last reported earnings were for reported on December 13, 2024 for Q3.
What were the latest earnings per share (EPS) for Galera Therapeutics (OTCPK:GRTX)?
The Actual EPS was $-0.10, which missed the estimate of $0.00.
What were Galera Therapeutics’s (OTCPK:GRTX) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.